NCT03169790 2025-02-24QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHLImmunityBio, Inc.Phase 1/2 Withdrawn
NCT03451825 2024-06-24Phase I/II Study of Avelumab in Pediatric Cancer ParticipantsEMD SeronoPhase 1 Terminated21 enrolled 21 charts